These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 8272873

  • 1. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
    Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S.
    Science; 1994 Jan 07; 263(5143):92-5. PubMed ID: 8272873
    [Abstract] [Full Text] [Related]

  • 2. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I.
    J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060
    [Abstract] [Full Text] [Related]

  • 3. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors.
    Boulton TG, Stahl N, Yancopoulos GD.
    J Biol Chem; 1994 Apr 15; 269(15):11648-55. PubMed ID: 7512571
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S, Fourcin M, Robledo O, Wijdenes J, Pouplard-Barthelaix A, Gascan H.
    J Biol Chem; 1996 Jun 21; 271(25):14764-72. PubMed ID: 8662918
    [Abstract] [Full Text] [Related]

  • 5. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC.
    J Clin Invest; 1996 Jan 15; 97(2):431-7. PubMed ID: 8567964
    [Abstract] [Full Text] [Related]

  • 6. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P.
    FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477
    [Abstract] [Full Text] [Related]

  • 7. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.
    Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD.
    Science; 1993 Jun 18; 260(5115):1805-8. PubMed ID: 8390097
    [Abstract] [Full Text] [Related]

  • 8. Signaling of type II oncostatin M receptor.
    Auguste P, Guillet C, Fourcin M, Olivier C, Veziers J, Pouplard-Barthelaix A, Gascan H.
    J Biol Chem; 1997 Jun 20; 272(25):15760-4. PubMed ID: 9188471
    [Abstract] [Full Text] [Related]

  • 9. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H, Friedrich M, Postert C, Ringelstein EB, Stögbauer F.
    Mol Cell Biol Res Commun; 1999 May 20; 1(2):109-16. PubMed ID: 10356359
    [Abstract] [Full Text] [Related]

  • 10. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves.
    Ito Y, Yamamoto M, Li M, Doyu M, Tanaka F, Mutch T, Mitsuma T, Sobue G.
    Brain Res; 1998 May 18; 793(1-2):321-7. PubMed ID: 9630704
    [Abstract] [Full Text] [Related]

  • 11. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway.
    Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N, Yancopoulos GD, Greenberg ME.
    Science; 1997 Oct 17; 278(5337):477-83. PubMed ID: 9334309
    [Abstract] [Full Text] [Related]

  • 12. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.
    Watanabe D, Yoshimura R, Khalil M, Yoshida K, Kishimoto T, Taga T, Kiyama H.
    Eur J Neurosci; 1996 Aug 17; 8(8):1630-40. PubMed ID: 8921254
    [Abstract] [Full Text] [Related]

  • 13. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H.
    Circulation; 2003 Feb 18; 107(6):798-802. PubMed ID: 12591746
    [Abstract] [Full Text] [Related]

  • 14. The soluble interleukin-6 receptor.
    Rose-John S, Ehlers M, Grötzinger J, Müllberg J.
    Ann N Y Acad Sci; 1995 Jul 21; 762():207-20; discussion 220-1. PubMed ID: 7668529
    [No Abstract] [Full Text] [Related]

  • 15. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
    Kasza A, Rogowski K, Kilarski W, Sobota R, Bernas T, Dobrucki J, Travis J, Koj A, Bugno M, Kordula T.
    Biochem J; 2001 Apr 15; 355(Pt 2):307-14. PubMed ID: 11284716
    [Abstract] [Full Text] [Related]

  • 16. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R.
    J Neurosurg; 1998 Mar 15; 88(3):541-8. PubMed ID: 9488310
    [Abstract] [Full Text] [Related]

  • 17. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C, Auguste P, Chabbert M, Lelièvre E, Chevalier S, Gascan H.
    J Biol Chem; 2000 Feb 25; 275(8):5648-56. PubMed ID: 10681548
    [Abstract] [Full Text] [Related]

  • 18. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):198-206. PubMed ID: 11038252
    [Abstract] [Full Text] [Related]

  • 19. Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor.
    Di Marco A, Gloaguen I, Demartis A, Saggio I, Graziani R, Paonessa G, Laufer R.
    J Biol Chem; 1997 Sep 12; 272(37):23069-75. PubMed ID: 9287306
    [Abstract] [Full Text] [Related]

  • 20. A sweat gland-derived differentiation activity acts through known cytokine signaling pathways.
    Habecker BA, Symes AJ, Stahl N, Francis NJ, Economides A, Fink JS, Yancopoulos GD, Landis SC.
    J Biol Chem; 1997 Nov 28; 272(48):30421-8. PubMed ID: 9374533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.